The role of multiple PARP inhibitors has also been evaluated in gastric cancer (GC) conditions as mutated homologous DNA recombination genes such as BRC1/2, PALB2, ATM, RAD51C, and ARID1A carry somatic HRD (Sahasrabudhe et al., 2017). This evidence concerns the gene ARID1A and gastric cancer.